metoprolol has been researched along with Cerebrovascular Disorders in 9 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of metoprolol treatment in patients surviving acute myocardial infarction have been investigated in a double-blind randomized study." | 9.05 | Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. ( Erhardt, L; Lundman, T; Olsson, G; Rehnqvist, N; Sjögren, A, 1985) |
| "The question whether initial antihypertensive treatment with a beta-blocker prevents hypertensive complications better than initial treatment with a non-betablocker, mainly diuretic based treatment, has been studied in recent large-scale studies like the Medical Research Council (MRC) trial, the International Prospective Primary Prevention Study in Hypertension (IPPPSH), the Heart Attack Primary Prevention in Hypertension (HAPPHY) study and the Metoprolol Atherosclerosis Prevention in Hypertensives (MAPHY) study." | 5.06 | Beta-blockers and diuretics. The HAPPHY and MAPHY studies. ( Berglund, G, 1989) |
| "The effects of metoprolol treatment in patients surviving acute myocardial infarction have been investigated in a double-blind randomized study." | 5.05 | Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. ( Erhardt, L; Lundman, T; Olsson, G; Rehnqvist, N; Sjögren, A, 1985) |
| "Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol." | 3.91 | Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019) |
| "3." | 1.29 | Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative. ( Karppanen, H; Laakso, J; Mervaala, EM; Vapaatalo, H, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sessa, M | 1 |
| Mascolo, A | 1 |
| Rasmussen, DB | 1 |
| Kragholm, K | 1 |
| Jensen, MT | 1 |
| Sportiello, L | 1 |
| Rafaniello, C | 1 |
| Tari, GM | 1 |
| Pagliaro, C | 1 |
| Andersen, M | 1 |
| Rossi, F | 1 |
| Capuano, A | 1 |
| Bolduc, V | 1 |
| Drouin, A | 1 |
| Gillis, MA | 1 |
| Duquette, N | 1 |
| Thorin-Trescases, N | 1 |
| Frayne-Robillard, I | 1 |
| Des Rosiers, C | 1 |
| Tardif, JC | 1 |
| Thorin, E | 1 |
| Naumann, UK | 1 |
| Käser, L | 1 |
| Vetter, W | 1 |
| Mervaala, EM | 1 |
| Laakso, J | 1 |
| Vapaatalo, H | 1 |
| Karppanen, H | 1 |
| Tuomilehto, J | 2 |
| Wikstrand, J | 2 |
| Warnold, I | 2 |
| Olsson, G | 3 |
| Elmfeldt, D | 2 |
| Berglund, G | 3 |
| Jonas, S | 1 |
| Rehnqvist, N | 1 |
| Sjögren, A | 1 |
| Erhardt, L | 1 |
| Lundman, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)[NCT02584439] | Phase 3 | 30 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for metoprolol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Coronary artery disease can be prevented by antihypertensive therapy: experiences from the MAPHY Study.
Topics: Adult; Antihypertensive Agents; Benzothiadiazines; Cerebrovascular Disorders; Coronary Disease; Deat | 1990 |
Beta-blockers and diuretics. The HAPPHY and MAPHY studies.
Topics: Adrenergic beta-Antagonists; Arteriosclerosis; Benzothiadiazines; Cerebrovascular Disorders; Coronar | 1989 |
Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.
Topics: Adult; Benzothiadiazines; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Diur | 1988 |
Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cerebrovascular Disorders; Clinical Trials as Topic; Co | 1985 |
5 other studies available for metoprolol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol | 2019 |
Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.
Topics: Animals; Anti-Arrhythmia Agents; Apolipoproteins B; Atherosclerosis; Benzazepines; Carotid Arteries; | 2011 |
[Arterial hypertension 3: Hypertensive crisis: hypertensive emergency and hypertensive urgency].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cereb | 2006 |
Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative.
Topics: Animals; Blood Pressure; Cerebrovascular Disorders; Eating; Electrolytes; Heart Rate; Hemodynamics; | 1994 |
The Physician's Health Study. A neurologist's concern.
Topics: Aspirin; Cerebrovascular Disorders; Cohort Studies; Follow-Up Studies; Humans; Male; Metoprolol; Myo | 1990 |